These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
145 related items for PubMed ID: 11205734
1. Dextran-methylprednisolone succinate as a prodrug of methylprednisolone: immunosuppressive effects after in vivo administration to rats. Mehvar R, Hoganson DA. Pharm Res; 2000 Nov; 17(11):1402-7. PubMed ID: 11205734 [Abstract] [Full Text] [Related]
2. Dextran-methylprednisolone succinate as a prodrug of methylprednisolone: in vitro immunosuppressive effects on rat blood and spleen lymphocytes. Rensberger KL, Hoganson DA, Mehvar R. Int J Pharm; 2000 Oct 10; 207(1-2):71-6. PubMed ID: 11036232 [Abstract] [Full Text] [Related]
3. Dextran-methylprednisolone succinate as a prodrug of methylprednisolone: plasma and tissue disposition. Zhang X, Mehvar R. J Pharm Sci; 2001 Dec 10; 90(12):2078-87. PubMed ID: 11745766 [Abstract] [Full Text] [Related]
4. Kinetics of hydrolysis of dextran-methylprednisolone succinate, a macromolecular prodrug of methylprednisolone, in rat blood and liver lysosomes. Mehvar R, Dann RO, Hoganson DA. J Control Release; 2000 Jul 31; 68(1):53-61. PubMed ID: 10884579 [Abstract] [Full Text] [Related]
5. Dextran-methylprednisolone succinate as a prodrug of methylprednisolone: local immunosuppressive effects in liver after systemic administration to rats. Chimalakonda AP, Mehvar R. Pharm Res; 2003 Feb 31; 20(2):198-204. PubMed ID: 12636157 [Abstract] [Full Text] [Related]
6. Hepatic immunosuppressive effects of systemically administered novel dextran-methylprednisolone prodrugs with peptide linkers in rats. Shaik IH, Agarwal HK, Parang K, Mehvar R. J Pharm Sci; 2012 Oct 31; 101(10):4003-12. PubMed ID: 22829462 [Abstract] [Full Text] [Related]
7. High-performance size-exclusion chromatographic analysis of dextran-methylprednisolone hemisuccinate in rat plasma. Mehvar R. J Chromatogr B Biomed Sci Appl; 2000 Jul 21; 744(2):293-8. PubMed ID: 10993517 [Abstract] [Full Text] [Related]
8. Plasma pharmacokinetics and tissue disposition of novel dextran-methylprednisolone conjugates with peptide linkers in rats. Penugonda S, Agarwal HK, Parang K, Mehvar R. J Pharm Sci; 2010 Mar 21; 99(3):1626-37. PubMed ID: 19780131 [Abstract] [Full Text] [Related]
9. Dextran-methylprednisolone succinate as a prodrug of methylprednisolone: dose-dependent pharmacokinetics in rats. Zhang X, Mehvar R. Int J Pharm; 2001 Oct 23; 229(1-2):173-82. PubMed ID: 11604270 [Abstract] [Full Text] [Related]
10. Decrease in oral bioavailability of ciclosporin by intravenous pulse of methylprednisolone succinate in rats. Konishi H, Sumi M, Shibata N, Takada K, Minouchi T, Yamaji A. J Pharm Pharmacol; 2004 Oct 23; 56(10):1259-66. PubMed ID: 15482640 [Abstract] [Full Text] [Related]
11. Influence of intravenous methylprednisolone pulse treatment on the disposition of ciclosporin and hepatic CYP3A activity in rats. Konishi H, Sumi M, Shibata N, Takada K, Minouchi T, Yamaji A. J Pharm Pharmacol; 2004 Apr 23; 56(4):477-83. PubMed ID: 15099443 [Abstract] [Full Text] [Related]
12. Simultaneous analysis of dextran-methylprednisolone succinate, methylprednisolone succinate, and methylprednisolone by size-exclusion chromatography. Mehvar R. J Pharm Biomed Anal; 1999 Apr 23; 19(5):785-92. PubMed ID: 10698542 [Abstract] [Full Text] [Related]
13. Synthesis and in vitro characterization of novel dextran-methylprednisolone conjugates with peptide linkers: effects of linker length on hydrolytic and enzymatic release of methylprednisolone and its peptidyl intermediates. Penugonda S, Kumar A, Agarwal HK, Parang K, Mehvar R. J Pharm Sci; 2008 Jul 23; 97(7):2649-64. PubMed ID: 17853426 [Abstract] [Full Text] [Related]
14. Pharmacokinetic and pharmacodynamic assessment of bioavailability for two prodrugs of methylprednisolone. Daley-Yates PT, Gregory AJ, Brooks CD. Br J Clin Pharmacol; 1997 Jun 23; 43(6):593-601. PubMed ID: 9205819 [Abstract] [Full Text] [Related]
15. Attenuation of acute rejection in a rat liver transplantation model by a liver-targeted dextran prodrug of methylprednisolone. Chimalakonda AP, Montgomery DL, Weidanz JA, Shaik IH, Nguyen JH, Lemasters JJ, Kobayashi E, Mehvar R. Transplantation; 2006 Mar 15; 81(5):678-85. PubMed ID: 16534468 [Abstract] [Full Text] [Related]
16. Immunodynamics of methylprednisolone induced T-cell trafficking and deactivation using whole blood lymphocyte proliferation techniques in the rat. Fasanmade AA, Jusko WJ. Biopharm Drug Dispos; 1999 Jul 15; 20(5):255-61. PubMed ID: 10594870 [Abstract] [Full Text] [Related]
17. Development of a macromolecular prodrug of FK 506: II: In vitro study for FK 506-dextran conjugate. Yura H, Yoshimura N, Hamashima T, Oka T, Takakura Y, Hashida M. Transplant Proc; 1998 Jun 15; 30(4):1031-2. PubMed ID: 9636416 [No Abstract] [Full Text] [Related]
18. Effects of duration of ischemia and donor pretreatment with methylprednisolone or its macromolecular prodrug on the disposition of indocyanine green in cold-preserved rat livers. Chimalakonda AP, Mehvar R. Pharm Res; 2004 Jun 15; 21(6):1000-8. PubMed ID: 15212166 [Abstract] [Full Text] [Related]
19. Simultaneous analysis of methylprednisolone, methylprednisolone succinate, and endogenous corticosterone in rat plasma. Mehvar R, Dann RO, Hoganson DA. J Pharm Biomed Anal; 2000 Jul 15; 22(6):1015-22. PubMed ID: 10857570 [Abstract] [Full Text] [Related]
20. Disposition of methylprednisolone and its sodium succinate prodrug in vivo and in perfused liver of rats: nonlinear and sequential first-pass elimination. Kong AN, Jusko WJ. J Pharm Sci; 1991 May 15; 80(5):409-15. PubMed ID: 1880717 [Abstract] [Full Text] [Related] Page: [Next] [New Search]